LoginSignup
immagine del profilo
Bimbam
@Klambam
1Anno·

Has anyone read news about $IBRX (+1,24%) or knows what is going on? Almost 300% in one month.

1
11 Commenti
immagine del profilo
Patrick ₿ateman@fastlane
1Anno
„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters
•
2
•
immagine del profilo
Yassin@RisingAktie
1Anno
Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(
•
2
•
Visualizza tutti 3 ulteriori risposte
immagine del profilo
Nico@itZNico
1Anno
"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar
•
1
•
immagine del profilo
Bimbam@Klambam
1Anno
@Clermit that did not run with as hoped. rebuy? 😂
•
1
•
Mostra la risposta
immagine del profilo
MarsEquities@CircusClown
1Anno
What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.
••
Visualizza tutti 2 ulteriori risposte
Partecipa alla conversazione
IscrivitiAccesso